Approval · Notice of Compliance 33824 · 2024
PLENVU: Notice of Compliance 33824
Issued August 16, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33824
- Date
- August 16, 2024
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLENVU | 02550938 | Cancelled Pre Market |
Medicinal ingredients
- ASCORBIC ACID 7.54 G per DOSE
- POLYETHYLENE GLYCOL 3350 140 G per DOSE
- POTASSIUM CHLORIDE 2.2 G per DOSE
- SODIUM ASCORBATE 48.11 G per DOSE
- SODIUM CHLORIDE 5.2 G per DOSE
- SODIUM SULFATE ANHYDROUS 9 G per DOSE